HCC1143（人乳腺癌細(xì)胞）

CBP60368

詢價(jià)

索取STR

產(chǎn)品描述

產(chǎn)品數(shù)據(jù)庫(kù)

I. General information
Synonyms:	HCC1143
Background:	HCC1143 is a poorly differentiated cell line that was initiated on August 30, 1994; it took 29 months to establish. HCC1143 was derived from an invasive ductal carcinoma with no lymph node metastases.
Species:	Homo sapiens, human
Tissue:	breast; mammary gland/duct
Disease:	TNM stage IIA, grade 3, primary ductal carcinoma
Gender:	female, 52 years adult, Caucasian
Morphology:	epithelial
Growth Mode:	adherent
DNA Profile:	Amelogenin: X CSF1PO: 10 D13S317: 12 D16S539: 11,13 D5S818: 11 D7S820: 12 THO1: 9.3 TPOX: 12 vWA: 16 Cobioer’s Cell Line Authentication Service
Culture Medium:	RPMI-1640+10%FBS HCC1143完全培養(yǎng)基，#CBP60368M We strongly suggest to purchase the complete medium from Cobioer.
Cryopreservation medium:	90%FBS+10%DMSO
Oncogene:	her2/neu -; p53 +
Genes Expressed:	Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Cellular Products:	Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Comments:	HCC1143 was derived from an invasive ductal carcinoma with no lymph node metastases. The cells are negative for expression of Her2-neu but positive for expression of p53. HCC1143 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 and for cytokeratin 19, and is negative for expression of estrogen receptor (ER) and progesterone receptor (PR). For more information, please contact Cobioer (4008-750-250).

相關(guān)產(chǎn)品推薦

? 4T1（小鼠乳腺癌細(xì)胞） ? AU565（人乳腺癌細(xì)胞） ? Bcap-37（人乳腺癌細(xì)胞（被Hela污染）） ? BT-20（人乳腺癌細(xì)胞） ? BT-474（人乳腺癌細(xì)胞） ? BT-483（人乳腺癌細(xì)胞） ? BT-549（人乳腺癌細(xì)胞） ? C127（小鼠乳腺腫瘤細(xì)胞） ? CAL-120（人乳腺癌細(xì)胞） ? CAL-148（人乳腺癌細(xì)胞）

返回列表